Other languages Theralink Technologies, Inc.

Equities

THER

US88339Q1094

Market Closed - OTC Markets Other stock markets 20:50:10 04/06/2024 BST			5-day change	1st Jan Change
0.0001 ^USD	0.00%		-85.71%	-93.33%

05-07	IMAC Holdings, Inc. acquired Assets of Theralink Technologies, Inc.	CI
05-06	Theralink Technologies, Inc. cancelled the acquisition of IMAC Holdings, Inc. in a reverse merger transaction.	CI

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

IMAC Holdings, Inc. acquired Assets of Theralink Technologies, Inc.	05-06
Theralink Technologies, Inc. cancelled the acquisition of IMAC Holdings, Inc. in a reverse merger transaction.	05-05
Theralink Technologies, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023	02-20
Theralink Technologies, Inc. Reports Earnings Results for the Full Year Ended September 30, 2023	01-05
Theralink Technologies, Inc. Announces Promising Interim Results on the Implementation of Proteomic Analysis into Inova Schar Cancer Institute?s Molecular Tumor Board	11-03
Theralink Technologies, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023	21/08/23
Theralink Technologies, Inc. Announces Chief Executive Officer Changes	27/06/23
Theralink Technologies, Inc. Appoints Mick Ruxin as Chief Medical Officer	27/06/23
Theralink Technologies, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023	15/05/23
Theralink Technologies, Inc. Announces Termination of Thomas Chilcott as Treasurer and Secretary	11/05/23
Theralink Technologies, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2022	21/02/23
Theralink Technologies Appoints Michael Vallone as Senior Director of Commercialization	09/01/23
Theralink Technologies, Inc. Reports Earnings Results for the Full Year Ended September 30, 2022	29/12/22
Theralink Technologies, Inc. Auditor Raises 'Going Concern' Doubt	28/12/22
Theralink Technologies, Inc. Appoints Faith Zaslavsky, as President & Chief Operating Officer for its Precision Oncology Company	06/12/22
Theralink Technologies, Inc. Appoints Mattia Cremona as Its Director of Its Biopharma Laboratory	07/11/22
Theralink Technologies, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2022	15/08/22
Theralink Technologies, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2022	23/05/22
Theralink Technologies Expands Adoption of Its Precision Medicine Technology in the Biopharmaceutical Industry	19/04/22
Theralink Technologies, Inc. Announces Board Appointments	06/04/22

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Theralink Technologies, Inc.

Equities

THER

US88339Q1094

Other languages

Filters